Clinical Trial

Ropustin for Refractory Aplastic Anaemia After Radiotherapy - a Single-centre, Prospective, Open-label, Single-arm Study

Unknown Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated July 24, 2024 (before its estimated July 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
To investigate the efficacy and safety of roprostin in the treatment of refractory AA after radiotherapy.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06516484
Lead Sponsor Peking Union Medical College Hospital
Conditions Aplastic Anemia
Enrollment 40 participants
Start Date 2024-07-30
Primary Completion 2025-07-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-07-24